Cardio-Oncology Drug Interactions: A Commentary With Dr Daniel Lenihan

Published: 31 Oct 2022

  • Views:

    Views Icon 104
  • Likes:

    Heart Icon 2
Average (ratings)
No ratings
Your rating

Dr Daniel Lenihan (The Center for Advanced Medicine, St Louis, MO, US) joins us to provide his commentary on the recently published AHA Scientific Statement for Cardio-Oncology Drug Interactions. 

Dr Lenihan is a cardio-oncologist specialising in cardiology, heart disease and advanced heart failure. He is the immediate past president of the International Cardio-Oncology Society.